Literature DB >> 20852188

Gamma interferon supplementation for melioidosis.

Gavin C K W Koh, Direk Limmathurotsakul.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852188      PMCID: PMC2944586          DOI: 10.1128/AAC.00805-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.

Authors:  Katie L Propst; Ryan M Troyer; Lisa M Kellihan; Herbert P Schweizer; Steven W Dow
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 2.  Melioidosis.

Authors:  Sharon J Peacock
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

3.  Halving of mortality of severe melioidosis by ceftazidime.

Authors:  N J White; D A Dance; W Chaowagul; Y Wattanagoon; V Wuthiekanun; N Pitakwatchara
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

4.  Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis.

Authors:  F N Lauw; A J Simpson; J M Prins; M D Smith; M Kurimoto; S J van Deventer; P Speelman; W Chaowagul; N J White; T van der Poll
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

Review 5.  Immunostimulation is a rational therapeutic strategy in sepsis.

Authors:  Jérôme Pugin
Journal:  Novartis Found Symp       Date:  2007

6.  Interferon-gamma increases mortality following cecal ligation and puncture.

Authors:  R H Miles; T P Paxton; D J Dries; R L Gamelli
Journal:  J Trauma       Date:  1994-05

7.  G-CSF immunotherapy for treatment of acute disseminated murine melioidosis.

Authors:  Kellie Powell; Glen Ulett; Robert Hirst; Robert Norton
Journal:  FEMS Microbiol Lett       Date:  2003-07-29       Impact factor: 2.742

8.  A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand.

Authors:  Allen C Cheng; Direk Limmathurotsakul; Wirongrong Chierakul; Nongluk Getchalarat; Vanaporn Wuthiekanun; Dianne P Stephens; Nicholas P J Day; Nicholas J White; Wipada Chaowagul; Bart J Currie; Sharon J Peacock
Journal:  Clin Infect Dis       Date:  2007-06-15       Impact factor: 9.079

9.  Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei.

Authors:  P Santanirand; V S Harley; D A Dance; B S Drasar; G J Bancroft
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

  9 in total
  3 in total

Review 1.  Emerging role of biologics for the treatment of melioidosis and glanders.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Alfredo G Torres
Journal:  Expert Opin Biol Ther       Date:  2019-10-15       Impact factor: 4.388

2.  Evaluation of surrogate animal models of melioidosis.

Authors:  Jonathan Mark Warawa
Journal:  Front Microbiol       Date:  2010-12-29       Impact factor: 5.640

3.  Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling.

Authors:  Gavin C K W Koh; M Fernanda Schreiber; Ruben Bautista; Rapeephan R Maude; Susanna Dunachie; Direk Limmathurotsakul; Nicholas P J Day; Gordon Dougan; Sharon J Peacock
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.